Platform Technology Partners Invests $359,000 in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Platform Technology Partners acquired a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 726 shares of the medical equipment provider's stock, valued at approximately $359,000.

Other institutional investors have also modified their holdings of the company. Brighton Jones LLC grew its holdings in Intuitive Surgical by 24.9% in the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider's stock valued at $1,916,000 after purchasing an additional 731 shares during the period. Bank Pictet & Cie Europe AG grew its stake in Intuitive Surgical by 0.5% during the fourth quarter. Bank Pictet & Cie Europe AG now owns 190,969 shares of the medical equipment provider's stock worth $99,678,000 after buying an additional 883 shares during the period. Proficio Capital Partners LLC grew its stake in Intuitive Surgical by 70.9% during the fourth quarter. Proficio Capital Partners LLC now owns 1,820 shares of the medical equipment provider's stock worth $950,000 after buying an additional 755 shares during the period. Moors & Cabot Inc. grew its stake in Intuitive Surgical by 8.4% during the fourth quarter. Moors & Cabot Inc. now owns 1,256 shares of the medical equipment provider's stock worth $656,000 after buying an additional 97 shares during the period. Finally, Commonwealth Equity Services LLC grew its stake in Intuitive Surgical by 5.9% during the fourth quarter. Commonwealth Equity Services LLC now owns 74,140 shares of the medical equipment provider's stock worth $38,698,000 after buying an additional 4,145 shares during the period. Institutional investors and hedge funds own 83.64% of the company's stock.

Insider Buying and Selling at Intuitive Surgical

In related news, EVP Gary Loeb sold 1,700 shares of the business's stock in a transaction that occurred on Friday, April 25th. The shares were sold at an average price of $513.18, for a total value of $872,406.00. Following the sale, the executive vice president directly owned 2,245 shares in the company, valued at $1,152,089.10. The trade was a 43.09% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Jami K. Nachtsheim sold 2,400 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the completion of the transaction, the director directly owned 6,371 shares in the company, valued at approximately $3,312,920. This trade represents a 27.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 4,998 shares of company stock valued at $2,611,577 over the last quarter. Company insiders own 0.70% of the company's stock.

Wall Street Analyst Weigh In

ISRG has been the subject of several research reports. Robert W. Baird decreased their price objective on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a research note on Wednesday, April 23rd. Royal Bank Of Canada decreased their price objective on shares of Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a research note on Wednesday, April 23rd. Barclays reduced their target price on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a research report on Thursday, April 24th. Deutsche Bank Aktiengesellschaft cut shares of Intuitive Surgical from a "hold" rating to a "sell" rating and reduced their target price for the stock from $515.00 to $440.00 in a research report on Monday, June 9th. Finally, BTIG Research set a $560.00 target price on shares of Intuitive Surgical and gave the stock a "buy" rating in a research report on Monday, April 14th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $592.59.

Intuitive Surgical Stock Performance

Shares of ISRG stock traded down $13.99 during midday trading on Friday, reaching $512.06. 2,951,229 shares of the company were exchanged, compared to its average volume of 1,682,083. Intuitive Surgical, Inc. has a 12 month low of $413.82 and a 12 month high of $616.00. The company has a market cap of $183.53 billion, a P/E ratio of 75.08, a PEG ratio of 5.43 and a beta of 1.64. The company's 50 day moving average price is $537.85 and its two-hundred day moving average price is $536.68.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. The company had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. During the same period in the previous year, the firm earned $1.50 EPS. As a group, sell-side analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.